Objectives/hypothesis: To evaluate the efficacy and reconstructive applications of angular vessel microvascular anastomosis in free-tissue transfer.
Study design: Retrospective cohort study.
Methods: A study of patients treated from January 2010 to July 2017 was performed. Four hundred thirty patients undergoing free-tissue transfer at the Cleveland Clinic by a single reconstructive surgeon were reviewed. Patients in whom free-tissue transfer was performed using angular vessels were included. Patients in whom free-tissue transfer was performed using another vascular supply of the head and neck were excluded. Primary outcome was free-flap failure. Secondary outcomes included other postoperative complications and hospital length of stay.
Results: Thirty-one patients underwent free-tissue transfer with microvascular anastomosis to the angular vessels during the study period. Seventy-one percent of patients underwent reconstruction immediately following tumor ablation. A variety of primary subsites were reconstructed; 58% underwent nasal reconstruction, 16% orbit/skull base reconstruction, 13% palatal reconstruction, 6% maxillary reconstruction, and 6% mandible reconstruction. Eighty-seven percent of patients underwent free-tissue transfer from an anterolateral thigh donor site. Ninety-seven percent of patients had successful free-tissue transfer with a viable flap during the follow-up period; only one patient experienced flap failure attributed to vascular insufficiency. Average length of stay was 4.7 days, and the most common length of stay was 3 days.
Conclusions: The angular vessels provide excellent arterial supply and venous drainage to serve as a viable option for microvascular anastomosis during free-tissue transfer for head and neck reconstructive surgery. They are an ideal vascular source for central face and skull base reconstruction.
Level of evidence: NA Laryngoscope, 130:2589-2592, 2020.
Keywords: Free-tissue transfer; angular artery and vein; head and neck reconstruction.
© 2020 The American Laryngological, Rhinological and Otological Society, Inc.